Pentwater Capital Management LP - Q2 2020 holdings

$5.62 Billion is the total value of Pentwater Capital Management LP's 159 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 100.0% .

 Value Shares↓ Weighting
ExitINTELSAT S Acall$0-30,000
-100.0%
-0.00%
CERS ExitCERUS CORP$0-22,500
-100.0%
-0.00%
VER ExitVEREIT INC$0-71,853
-100.0%
-0.01%
EWU ExitISHARES TRmsci uk etf new$0-15,000
-100.0%
-0.01%
PTON ExitPELOTON INTERACTIVE INC$0-15,314
-100.0%
-0.01%
TENB ExitTENABLE HLDGS INC$0-21,152
-100.0%
-0.01%
LVGO ExitLIVONGO HEALTH INC$0-16,067
-100.0%
-0.01%
WSC ExitWILLSCOT CORP$0-66,000
-100.0%
-0.01%
ExitDYNATRACE INCput$0-33,300
-100.0%
-0.01%
O ExitREALTY INCOME CORP$0-20,000
-100.0%
-0.02%
ExitINTELSAT S Anote 4.500% 6/15/25$0-8,300,000
-100.0%
-0.03%
ExitFIRST HORIZON NATL CORPcall$0-250,000
-100.0%
-0.03%
ExitHUMANA INCcall$0-8,000
-100.0%
-0.04%
ExitAMERICAN AIRLS GROUP INCcall$0-220,000
-100.0%
-0.04%
UNH ExitUNITEDHEALTH GROUP INC$0-18,084
-100.0%
-0.07%
HUM ExitHUMANA INC$0-20,960
-100.0%
-0.11%
ExitBOEING COcall$0-46,600
-100.0%
-0.12%
ExitUNITEDHEALTH GROUP INCput$0-31,600
-100.0%
-0.13%
ExitHUMANA INCput$0-28,700
-100.0%
-0.15%
ExitUNITEDHEALTH GROUP INCcall$0-38,400
-100.0%
-0.16%
FG ExitFGL HLDGS$0-1,695,228
-100.0%
-0.27%
RARX ExitRA PHARMACEUTICALS INC$0-978,700
-100.0%
-0.78%
ExitSPDR S&P 500 ETF TRcall$0-210,000
-100.0%
-0.89%
ExitDISNEY WALT COput$0-595,100
-100.0%
-0.95%
AXE ExitANIXTER INTL INC$0-684,884
-100.0%
-0.99%
ExitALLERGAN PLCput$0-395,000
-100.0%
-1.16%
TECD ExitTECH DATA CORP$0-613,803
-100.0%
-1.33%
ExitT MOBILE US INCcall$0-1,000,000
-100.0%
-1.39%
S ExitSPRINT CORPORATION$0-12,549,000
-100.0%
-1.79%
WBC ExitWABCO HLDGS INC$0-943,130
-100.0%
-2.10%
FTSV ExitFORTY SEVEN INC$0-1,494,400
-100.0%
-2.36%
ExitMELLANOX TECHNOLOGIES LTDput$0-2,050,000
-100.0%
-4.11%
CY ExitCYPRESS SEMICONDUCTOR CORP$0-10,969,263
-100.0%
-4.22%
AGN ExitALLERGAN PLC$0-1,694,042
-100.0%
-4.96%
MLNX ExitMELLANOX TECHNOLOGIES LTD$0-3,087,476
-100.0%
-6.19%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BK OF AMERICA CORP42Q3 20230.1%
ESPERION THERAPEUTICS INC NE39Q2 20232.2%
SPDR S&P 500 ETF TR37Q2 202229.4%
SPDR S&P 500 ETF TR35Q3 202311.8%
SYNCHRONY FINL35Q3 20232.7%
WILLIAMS COS INC DEL35Q3 20231.4%
TURQUOISE HILL RESOURCES LTD30Q3 202011.0%
SPDR S&P 500 ETF TR28Q2 20227.3%
NXP SEMICONDUCTORS N V27Q3 202314.1%
SYNCHRONY FINL23Q4 20211.6%

View Pentwater Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Pentwater Capital Management LP Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
MONEYGRAM INTERNATIONAL INCFebruary 14, 20235,855,0006.1%
SIERRA WIRELESS INCFebruary 14, 20232,190,0005.6%
TURQUOISE HILL RESOURCES LTD.November 21, 202230,358,38215.1%
Poseida Therapeutics, Inc.April 25, 20224,967,2277.9%
COHERENT INCFebruary 11, 20221,402,0005.7%
Nuance Communications, Inc.February 11, 202217,340,0005.4%
CORELOGIC, INC.February 18, 20213,850,0005.3%
Esperion Therapeutics, Inc.February 16, 2021722,5802.6%
ACHILLION PHARMACEUTICALS INCFebruary 14, 20207,511,7005.4%
SILVERBOW RESOURCES, INC.February 14, 2020501,6984.3%

View Pentwater Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14

View Pentwater Capital Management LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (5615135000.0 != 5615143000.0)

Export Pentwater Capital Management LP's holdings